Plasminogen activator inhibitor-1 (PAI-1) promotes ECM accumulation by regulating fibrinolysis and plasmin-mediated matrix metalloproteinase activation and is strongly induced in various forms of kidney diseases including DKD [26]. Here, SERPINE1 is linked to diabetic kidney disease.